Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2014

01.02.2014 | Review

Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube

verfasst von: Johannes Dietl

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Among all gynecological malignancies, ovarian cancer is associated with the highest rate of mortality. Recent findings now propose a pivotal role for the fallopian tube during ovarian cancer pathogenesis.

New insights

Until recently, ovarian cancer was thought to derive from the ovarian surface epithelium. Nevertheless, attempts to define a precursor lesion from this tissue failed. Instead, prophylactic surgery performed on BRCA mutation carriers and subsequent histological analyses revealed a characteristic pre-neoplastic alteration at the fimbriated end of the fallopian tubes, the so-called serous tubal intraepithelial carcinoma (STIC). By morphology and molecular genetics, STIC was found to resemble serous ovarian cancer. As STIC can also be detected in >60 % of BRCA-unrelated serous ovarian carcinomas, it is now considered to be the precursor of the most common ovarian cancer subtype.

Consequences

Based on this hypothesis, a salpingectomy, i.e., the removal of the post-reproductive fallopian tubes may remove the actual site of tumorigenesis and thereby prevent spreading over the ovarian surface and throughout the peritoneum. Consequently, prophylactic salpingectomy might protect against serous ovarian cancer. Moreover, the procedure interrupts the connection between the uterine cavity and the lesser pelvis. Hence, it prevents the ascension of exfoliated endometrial cells which will likely reduce the incidence of endometrioid and clear cell ovarian cancers. Increasing evidence suggests that serous ovarian cancer originates from the fimbriated distal end of the fallopian tube, whereas the ovary gets only involved at a later stage.

Conclusion

Given the lack of suitable screening or early detection strategies for ovarian cancer, post-reproductive salpingectomy deserves serious consideration as a prophylactic intervention that will likely confer significant protection against an often deadly disease.
Literatur
1.
Zurück zum Zitat Dietl J, Marzusch K (1993) Ovarian surface epithelium and human ovarian cancer: a review. Gynecol Obstet Invest 35:129–135PubMedCrossRef Dietl J, Marzusch K (1993) Ovarian surface epithelium and human ovarian cancer: a review. Gynecol Obstet Invest 35:129–135PubMedCrossRef
2.
3.
Zurück zum Zitat Häusler S, Keller A, Chandran AP et al (2010) A new approach for ovarian cancer screening -characterization of miRNA profiles in peripheral blood. Br J Cancer 103:693–700PubMedCentralPubMedCrossRef Häusler S, Keller A, Chandran AP et al (2010) A new approach for ovarian cancer screening -characterization of miRNA profiles in peripheral blood. Br J Cancer 103:693–700PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Seidman JD, Cho KR, Ronnett BM, Kurman RJ (2011) Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM (eds) Blaustein’s pathology of the female genital tract, 6th edn. pp 679–784 Seidman JD, Cho KR, Ronnett BM, Kurman RJ (2011) Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM (eds) Blaustein’s pathology of the female genital tract, 6th edn. pp 679–784
5.
Zurück zum Zitat le Shih M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518PubMedCrossRef le Shih M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518PubMedCrossRef
6.
Zurück zum Zitat Blaustein A (1984) Peritoneal mesothelium and ovarian surface cells – shared characteristics. Int J Gynecol Pathol 3:361–375PubMedCrossRef Blaustein A (1984) Peritoneal mesothelium and ovarian surface cells – shared characteristics. Int J Gynecol Pathol 3:361–375PubMedCrossRef
7.
Zurück zum Zitat Marquez RT, Baggerly KA, Patterson AP et al (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11:6116–6126PubMedCrossRef Marquez RT, Baggerly KA, Patterson AP et al (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11:6116–6126PubMedCrossRef
8.
Zurück zum Zitat McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 oder BRCA2 mutations: a case–control study. Lancet Oncol 8:26–34PubMedCrossRef McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 oder BRCA2 mutations: a case–control study. Lancet Oncol 8:26–34PubMedCrossRef
9.
10.
Zurück zum Zitat Johnson PA, Gilles JR (2013) The hen as a model of ovarian cancer. Nat Rev Cancer 13:432–436PubMedCrossRef Johnson PA, Gilles JR (2013) The hen as a model of ovarian cancer. Nat Rev Cancer 13:432–436PubMedCrossRef
12.
Zurück zum Zitat Auersperg N (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30:12–21PubMedCrossRef Auersperg N (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30:12–21PubMedCrossRef
13.
Zurück zum Zitat Flesken-Nikitin A, Hwang C-I, Cheng C-Y et al (2013) Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche. Nature 495:241–245PubMedCrossRef Flesken-Nikitin A, Hwang C-I, Cheng C-Y et al (2013) Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche. Nature 495:241–245PubMedCrossRef
14.
Zurück zum Zitat Boyd C, McCluggage WG (2012) Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Am J Surg Pathol 36:368–375PubMedCrossRef Boyd C, McCluggage WG (2012) Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Am J Surg Pathol 36:368–375PubMedCrossRef
15.
16.
Zurück zum Zitat Piek JM, van Diest PJ, Zweemer RP et al (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451–456PubMedCrossRef Piek JM, van Diest PJ, Zweemer RP et al (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451–456PubMedCrossRef
17.
Zurück zum Zitat Przybycin CG, Kurman RJ, Ronnett BM et al (2010) Are all pelvic (non uterina) serous carcinomas of tubal origin? Am J Surg Pathol 34:1407–1416PubMedCrossRef Przybycin CG, Kurman RJ, Ronnett BM et al (2010) Are all pelvic (non uterina) serous carcinomas of tubal origin? Am J Surg Pathol 34:1407–1416PubMedCrossRef
18.
Zurück zum Zitat Piek JM, Verheijen RM, Kenemans P et al (2003) BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol 90:491PubMedCrossRef Piek JM, Verheijen RM, Kenemans P et al (2003) BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol 90:491PubMedCrossRef
19.
Zurück zum Zitat Kindelberger DM, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161–169PubMedCrossRef Kindelberger DM, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161–169PubMedCrossRef
20.
Zurück zum Zitat Kuhn E, Kurman RJ, Vang R et al (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma – evidence supporting the clonal relationship of the two lesions. J Pathol 226:421–426PubMedCrossRef Kuhn E, Kurman RJ, Vang R et al (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma – evidence supporting the clonal relationship of the two lesions. J Pathol 226:421–426PubMedCrossRef
21.
Zurück zum Zitat Fleming JS, Beaugie CR, Hariv I et al (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypothesis. Mol Cell Endocrinol 247:4–21PubMedCrossRef Fleming JS, Beaugie CR, Hariv I et al (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypothesis. Mol Cell Endocrinol 247:4–21PubMedCrossRef
22.
Zurück zum Zitat La Vecchia C (2006) Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 15:117–124PubMedCrossRef La Vecchia C (2006) Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 15:117–124PubMedCrossRef
23.
24.
Zurück zum Zitat Veras E, Mao TL, Ayhan A et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behaviour: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853PubMedCrossRef Veras E, Mao TL, Ayhan A et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behaviour: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853PubMedCrossRef
25.
26.
Zurück zum Zitat Yamamoto S, Tsuda H, Takano M et al (2011) PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinomas. J Pathol 225:189–194PubMedCrossRef Yamamoto S, Tsuda H, Takano M et al (2011) PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinomas. J Pathol 225:189–194PubMedCrossRef
27.
Zurück zum Zitat Hull ML, Escareno CR, Godsland JM et al (2008) Endometrial–peritoneal interactions during endometriotic lesion establishment. Am J Pathol 173:700–715PubMedCrossRef Hull ML, Escareno CR, Godsland JM et al (2008) Endometrial–peritoneal interactions during endometriotic lesion establishment. Am J Pathol 173:700–715PubMedCrossRef
28.
Zurück zum Zitat Sieh W, Salvador S, McGuire V et al (2013) Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case–control studies. Int J Epidemiol 42:579–589PubMedCrossRef Sieh W, Salvador S, McGuire V et al (2013) Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case–control studies. Int J Epidemiol 42:579–589PubMedCrossRef
29.
Zurück zum Zitat Vang R, Shih le-M, Kurman RJ (2013) Fallopian tube precursors of ovarian low- and high-grade serous neplasms. Histopathology 62:44–58PubMedCrossRef Vang R, Shih le-M, Kurman RJ (2013) Fallopian tube precursors of ovarian low- and high-grade serous neplasms. Histopathology 62:44–58PubMedCrossRef
31.
Zurück zum Zitat Dietl J, Wischhusen J, Häusler FS (2011) The post-reproductive fallopian tube: better removed? Hum Reprod 26:2918–2924PubMedCrossRef Dietl J, Wischhusen J, Häusler FS (2011) The post-reproductive fallopian tube: better removed? Hum Reprod 26:2918–2924PubMedCrossRef
32.
Zurück zum Zitat Crum CP, McKeon FD, Xian W (2011) BRCA, the oviduct and the space and time continium of pelvic serous carcinogenesis. Int J Gynecol Cancer 22:S29–S34CrossRef Crum CP, McKeon FD, Xian W (2011) BRCA, the oviduct and the space and time continium of pelvic serous carcinogenesis. Int J Gynecol Cancer 22:S29–S34CrossRef
33.
Zurück zum Zitat Lorusso D, Di Rocco R, Mancini M, Raspagliesi F (2013) High-grade serous tumor arising from fallopian tube in a BRCA mutation carrier after prophylactic oophorectomy. Case Rep Oncol 6:21–24PubMedCentralPubMedCrossRef Lorusso D, Di Rocco R, Mancini M, Raspagliesi F (2013) High-grade serous tumor arising from fallopian tube in a BRCA mutation carrier after prophylactic oophorectomy. Case Rep Oncol 6:21–24PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Greene MH, Mai PL, Schwartz PE (2011) Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 204:19e-1–6 Greene MH, Mai PL, Schwartz PE (2011) Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 204:19e-1–6
35.
Zurück zum Zitat Anderson CK, Wallace S, Guiahi M et al (2013) Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer 23:417–421PubMedCrossRef Anderson CK, Wallace S, Guiahi M et al (2013) Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer 23:417–421PubMedCrossRef
36.
Zurück zum Zitat Kwon JS, Tinker A, Pansegrau G et al (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121:14–24PubMed Kwon JS, Tinker A, Pansegrau G et al (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121:14–24PubMed
37.
Zurück zum Zitat Parker WH, Broder MS, Chang E et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113:1027–1037PubMedCentralPubMed Parker WH, Broder MS, Chang E et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113:1027–1037PubMedCentralPubMed
38.
Zurück zum Zitat Morelli M, Venturella R, Mocciaro R et al (2013) Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 129:448–451PubMedCrossRef Morelli M, Venturella R, Mocciaro R et al (2013) Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 129:448–451PubMedCrossRef
39.
Zurück zum Zitat Gao FF, Bhargara R, Yang H, et al. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum Pathol. 2013 (Epub ahead of print) Gao FF, Bhargara R, Yang H, et al. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum Pathol. 2013 (Epub ahead of print)
40.
Zurück zum Zitat Westgren M (2012) Prevention of ovarian cancer – let’s do something. AOGS 91:1009–1010CrossRef Westgren M (2012) Prevention of ovarian cancer – let’s do something. AOGS 91:1009–1010CrossRef
41.
Zurück zum Zitat Erickson BK, Conner MG, Landon CN: The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 2013 (Epub ahead of print) Erickson BK, Conner MG, Landon CN: The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 2013 (Epub ahead of print)
42.
Zurück zum Zitat Collins JM, Domchek SM, Huntsman DG, Mitchell G (2011) The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol 12:1089–1091PubMedCrossRef Collins JM, Domchek SM, Huntsman DG, Mitchell G (2011) The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol 12:1089–1091PubMedCrossRef
Metadaten
Titel
Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
verfasst von
Johannes Dietl
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2014
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-013-3041-3

Weitere Artikel der Ausgabe 2/2014

Archives of Gynecology and Obstetrics 2/2014 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.